T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning
about
Clinical Images: Imaging Manifestations of Orbital Neurofibromatosis Type 1.Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculatureCharacterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysisDoes cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerismsNeural phenotypes of common and rare genetic variants.Optic nerve tortuosity in children with neurofibromatosis type 1Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.Emerging genotype-phenotype relationships in patients with large NF1 deletions.A neuropsychological perspective on attention problems in neurofibromatosis type 1.Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disordersWhite matter microstructure of patients with neurofibromatosis type 1 and its relation to inhibitory control.Evaluation of the basal ganglia in neurofibromatosis type 1.Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting.Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.Relations between fine motor skill and parental report of attention in young children with neurofibromatosis type 1.Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome.Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1.Social information processing in children and adolescents with neurofibromatosis type 1.Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge.The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.Attention Deficit Hyperactivity Disorder in Neurofibromatosis Type 1: Evaluation with a Continuous Performance Test.Longitudinal assessment of cognition and T2-hyperintensities in NF1: An 18-year studyAttention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per SeCerebellar radiological abnormalities in children with neurofibromatosis type 1: part 1 - clinical and neuroimaging findings
P2860
Q30367654-BF99E015-DB74-4C7E-81BD-F9F2C16311BDQ30440266-C0113768-C593-4E9B-AD39-9085046336FEQ30831641-876D58C8-A04E-4BE8-B61F-E40CFD0899A0Q35007679-830738B4-5F9E-4294-800F-08004A361414Q35925439-B666C3FB-6C58-47E8-8DBC-EF7C6C0BD811Q36165240-66CE013D-CC27-463F-988F-162285FEED67Q36874111-68A2505B-95F8-4924-B93E-8D621906322BQ37522652-06726774-A889-4328-A222-1C45BC88FD72Q37707250-BBDF496F-8767-4FDB-B764-5C128CCB2056Q37725901-6C632DFF-80ED-4305-BFDB-5F488DB4736DQ37987047-6FC3DAE9-816C-40D6-82B0-39A2AD850136Q38012453-85F30767-F5C1-40A5-AA76-8CDE46499B5FQ38802252-5D806E7D-6057-4FF8-8503-00B983203C93Q42442141-7B5F9571-1523-4BA0-A8E9-05707EEEAD63Q42478604-BCBD4C1C-7318-48FC-B570-423549618D44Q42512482-3A495893-DB2C-41E5-8BB2-EB7F3E8D3992Q42662364-03EBDFAF-3372-45F0-9CB4-3F2A21223C07Q44244825-E0065712-E862-4AA1-AE0B-B63C86900154Q44325202-C5285335-F3A8-4557-93DC-0093B5C938E0Q44831386-6297004A-FD2F-4736-91A1-93611D7A5B25Q47150280-FAB0BC3C-A638-4681-BDB2-4F052F41F7B1Q47963126-A93D27F9-E672-4576-AFB9-3C283FAE927DQ48657970-DE7CE366-BC8C-4FE1-AF21-C69B3CAE6DD9Q50705090-A84D7284-E683-4184-B1A3-263E17DA085FQ53120030-31EEBBDE-01D9-423A-A1EB-939EDBF7B552Q53126759-D72F7940-8983-410C-9333-35B880EB1A29Q54965162-C5C43E4C-9A84-439D-829F-3E920E6F538AQ57394253-419BABA8-E515-49E5-8AF7-E7CF5BAE5F65Q57581441-14714486-97B6-45A1-B757-1438F0A841B8Q58547444-6338BB61-6CA7-4D04-A83D-2773AA5CD43D
P2860
T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
T2 hyperintensities in childre ...... nship to cognitive functioning
@ast
T2 hyperintensities in childre ...... nship to cognitive functioning
@en
T2 hyperintensities in childre ...... nship to cognitive functioning
@en-gb
T2 hyperintensities in childre ...... nship to cognitive functioning
@nl
type
label
T2 hyperintensities in childre ...... nship to cognitive functioning
@ast
T2 hyperintensities in childre ...... nship to cognitive functioning
@en
T2 hyperintensities in childre ...... nship to cognitive functioning
@en-gb
T2 hyperintensities in childre ...... nship to cognitive functioning
@nl
prefLabel
T2 hyperintensities in childre ...... nship to cognitive functioning
@ast
T2 hyperintensities in childre ...... nship to cognitive functioning
@en
T2 hyperintensities in childre ...... nship to cognitive functioning
@en-gb
T2 hyperintensities in childre ...... nship to cognitive functioning
@nl
P2860
P50
P356
P1476
T2 hyperintensities in childre ...... nship to cognitive functioning
@en
P2093
Adam Steinberg
Shelley L Hyman
P2860
P304
P356
10.1136/JNNP.2006.108134
P407
P577
2007-10-01T00:00:00Z